Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 2,846 shares at $37.10 ($106K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $106k DNLI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.10 | 1,423 | $53K | 50.0% |
| 2 | $37.10 | 1,423 | $53K | 50.0% |
| Total | $37.10 avg | 2,846 | $106K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |